SABSW — Sab Biotherapeutics Inc W Exp 10/22/202
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 10 SEC-registered investment managers reported holding SABSW (Sab Biotherapeutics Inc W Exp 10/22/202) in their latest 13F filings, with a combined reported value of $13.56K across 968.37K shares. That is -0.8% by share count (-7.82K shares) versus the previous quarter, while reported value moved +8.4%. Ownership is concentrated: the five largest holders account for 91.9% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of Sab Biotherapeutics Inc W Exp 10/22/202 (SABSW) include Shaolin Capital Management LLC, Marshall Wace, JPMorgan Chase & Co, ranked by reported 13F value among the 23 institutional holders on this page.
SABSW is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 10 | 968.37K | $13.56K | -0.8% |
| Q2 2026 | 9 | 941.52K | $12.06K | +0.5% |
| Q1 2026 | 8 | 936.76K | $24.33K | -0.6% |
| Q4 2025 | 9 | 400.54K | $12.24K | -4.6% |
| Q3 2025 | 12 | 954.50K | $22.46K | -2.7% |
| Q2 2025 | 7 | 848.58K | $28.25K | +0.0% |
| Q1 2025 | 10 | 1.07M | $34.81K | -1.5% |
| Q4 2024 | 11 | 1.00M | $75.74K | -20.5% |
Over the 8 quarters shown, institutional share counts decreased 4% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (-20.5%).
Top Institutional Holders (Q3 2026) — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 539.59K | $7.55K | 0.00% | Hold | |
| 146.44K | $2.05K | 0.00% | Hold | |
| 79.01K | $1.11K | 0.00% | Hold | |
| 62.50K | $875 | 0.00% | Hold | |
| 62.50K | $875 | 0.00% | Hold | |
| 37.91K | $531 | 0.00% | New | |
| 33.80K | $473 | 0.00% | Reduce | |
| 6.27K | $88 | 0.00% | Reduce | |
| 300 | $4 | 0.00% | Hold | |
| 48 | $1 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 539.59K | $6.91K | 0.00% | Hold | |
| 146.44K | $1.87K | 0.00% | Hold | |
| 79.03K | $1.01K | 0.00% | Hold | |
| 62.50K | $800 | 0.00% | Hold | |
| 62.50K | $800 | 0.00% | Hold | |
| 41.30K | $537 | 0.00% | Add | |
| 6.57K | $85 | 0.00% | Add | |
| 3.29K | $42 | 0.00% | Add | |
| 300 | $4 | 0.00% | New |
Q1 2026 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 539.59K | $14.08K | 0.00% | New | |
| 146.44K | $3.71K | 0.00% | Hold | |
| 78.73K | $2.06K | 0.00% | Hold | |
| 62.50K | $1.63K | 0.00% | Hold | |
| 62.50K | $1.63K | 0.00% | Hold | |
| 41.00K | $1.07K | 0.00% | Hold | |
| 4.19K | $105 | 0.00% | Reduce | |
| 1.81K | $47 | 0.00% | Hold |
Q4 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 146.44K | $4.57K | 0.00% | Hold | |
| 78.83K | $2.46K | 0.00% | Hold | |
| 62.50K | $1.95K | 0.00% | Hold | |
| 62.50K | $1.95K | 0.00% | Hold | |
| 41.10K | $1.03K | 0.00% | New | |
| 6.19K | $192 | 0.00% | Reduce | |
| 1.81K | $57 | 0.00% | Hold | |
| 1.07K | $33 | 0.00% | Hold | |
| 100 | $3 | 0.00% | Reduce |
Q3 2025 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 539.59K | $12.63K | 0.00% | Hold | |
| 146.44K | $3.43K | 0.00% | Hold | |
| 79.03K | $1.85K | 0.00% | New | |
| 62.50K | $1.46K | 0.00% | Hold | |
| 62.50K | $1.46K | 0.00% | Hold | |
| 26.30K | $750 | 0.00% | New | |
| 23.41K | $539 | 0.00% | New | |
| 11.44K | $268 | 0.00% | Reduce | |
| 1.81K | $42 | 0.00% | Reduce | |
| 1.07K | $25 | 0.00% | Hold | |
| 200 | $5 | 0.00% | New | |
| 200 | $5 | 0.00% | New |
Q2 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 539.59K | $17.97K | 0.00% | Hold | |
| 146.44K | $4.88K | 0.00% | Hold | |
| 62.50K | $2.08K | 0.00% | Hold | |
| 62.50K | $2.08K | 0.00% | Hold | |
| 31.86K | $1.06K | 0.00% | Hold | |
| 4.62K | $153 | 0.00% | Hold | |
| 1.07K | $35 | 0.00% | Hold |
New Positions (Q3 2026)
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 37.91K sh · $531
- Tower Research Capital LLC (TRC) 48 sh · $1
Fully Exited (vs previous quarter)
- WOLVERINE ASSET MANAGEMENT LLC sold 3.29K sh · $42
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LMR Partners LLP | 539.59K | 539.59K | 539.59K | — | 539.59K | 539.59K | 539.59K | 539.59K | 539.59K | 539.59K | 539.59K | 539.59K | 539.59K | — | — | — | — | — | — | — |
| Morgan Stanley | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 146.44K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 148.94K | 150.85K | 31.41K |
| Clear Street Group Inc. | 79.01K | 79.03K | 78.73K | 78.83K | 79.03K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MILLENNIUM MANAGEMENT LLC | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | — | — | — | — | — | — | — |
| Millennium Management | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K | 62.50K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 37.91K | — | — | — | 26.30K | — | — | — | — | — | 12.37K | — | — | — | — | — | — | — | — | — |
| GTS SECURITIES LLC | 33.80K | 41.30K | 41.00K | 41.10K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 6.27K | 6.57K | 4.19K | 6.19K | 23.41K | — | — | 1.63K | — | 56 | — | 29.08K | — | 100 | — | — | 5.61K | — | — | 2.89K |
| TORONTO DOMINION BANK | 300 | 300 | — | — | 200 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 48 | — | — | — | — | — | — | 48 | 48 | 48 | 48 | 48 | 48 | — | — | — | — | — | — | — |
| Shaolin Capital Management LLC | — | — | — | — | — | — | — | — | — | 249.14K | 292.96K | 371.64K | 465.72K | — | — | — | — | — | — | — |
| HB Wealth Management, LLC | — | — | — | — | — | — | 60.00K | 50.00K | 310.00K | — | — | — | — | — | — | — | — | — | — | — |
| Yakira Capital Management, Inc. | — | — | — | — | — | — | 78.73K | 93.23K | 108.48K | 108.48K | 108.48K | 108.48K | 108.48K | — | — | — | — | — | — | — |
| Walleye Trading LLC | — | — | — | — | 11.44K | 31.86K | 31.86K | 38.76K | 15.51K | 15.51K | 15.51K | 15.51K | 15.51K | — | — | — | — | — | — | — |
| Tabor Asset Management, LP | — | — | — | — | — | — | 78.73K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Walleye Capital LLC | — | — | — | — | — | — | — | — | 23.26K | 23.26K | 23.26K | 23.26K | 23.26K | — | — | — | — | — | — | — |
| WOLVERINE ASSET MANAGEMENT LLC | — | 3.29K | 1.81K | 1.81K | 1.81K | 4.62K | 4.62K | 8.65K | 15.52K | 15.32K | 22.78K | 22.81K | 12.77K | — | — | — | — | — | — | — |
| NewEdge Advisors, LLC | — | — | — | 1.07K | 1.07K | 1.07K | 1.07K | 1.07K | 1.07K | 1.07K | 1.07K | 1.07K | 1.07K | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | — | 100 | 200 | — | — | — | — | 200 | 100 | — | — | — | — | — | — | — | — | — |
| Balyasny Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 281.11K | 281.11K | 281.11K | 281.11K | 281.11K | 281.11K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SABSW?
As of 2026-Q3, 10 institutional funds reported holding SABSW (Sab Biotherapeutics Inc W Exp 10/22/202) in SEC 13F filings, with a combined reported value of $13.56K.
How many shares of SABSW do institutions own?
13F filers reported 968.37K shares of SABSW, worth $13.56K in aggregate at the end of 2026-Q3.
Is institutional ownership of SABSW rising or falling?
Share counts moved -0.8% versus the prior quarter — distribution.
Who are the top institutional holders of SABSW?
The largest 13F holders are Shaolin Capital Management LLC, Marshall Wace, JPMorgan Chase & Co, Balyasny Asset Management, LMR Partners LLP; the top 25 are ranked at the top of this page.
Who are the major shareholders of Sab Biotherapeutics Inc W Exp 10/22/202?
The major shareholders of Sab Biotherapeutics Inc W Exp 10/22/202 (SABSW) by reported 13F value are Shaolin Capital Management LLC, Marshall Wace, JPMorgan Chase & Co, Balyasny Asset Management, LMR Partners LLP, among 23 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.